MSCI vs TECH · P/E 37, rev $2.86B vs P/E 65, rev $1.22B
MSCI Inc (MSCI) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
MSCI Inc (MSCI) is a financial data & stock exchanges company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MSCI revenue for 2024-12-31 was $2.86B. Net income was $1.11B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. MSCI currently screens at market cap $46.82B and trailing P/E 36.8.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MSCI currently screens at market cap $46.82B and trailing P/E 36.8. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MSCI and TECH stock pages for the full models.
Not investment advice.